Enhance your practice with CME and tools that focus on the management of neurological conditions.
Navigating Stem Cell Therapy Conversations in MS
Jaime Imitola, MD
Understanding Disparities in Migraine Diagnosis: Evidence from Real-World Data
Juliana VanderPluym, MD
The Critical Next Steps After Subarachnoid Hemorrhage Diagnosis
Jay Max Findlay
Spotting the Warning Signs of Subarachnoid Hemorrhage
Evaluating Delayed Presentations of Subarachnoid Hemorrhage
Mobilization Outcomes After Aneurysmal Subarachnoid Hemorrhage
Consensus-Driven Outcomes for Aneurysmal Subarachnoid Hemorrhage Research
Movements With Meaning: Reading the Pattern, Not the Label
Karen E. Anderson, MD
Hubert H. Fernandez, MD
Shared Decisions, Real Patients: Patient-Centered TD and Antipsychotic Strategies
Tracy Hicks, DNP, MBA
Melissa Moody, MD
Closing the Gap: Equity, Disparities, and Access to TD Diagnosis and Care
VMAT2 in the Real World: Recently Presented PRO Data That Should Change TD Practice
Tardive Dyskinesia, Decoded: From Subtle Signs to Personalized VMAT2 Therapy
The Role of CGRPs in First-Line Preventive Migraine Therapy
Charles Turck, PharmD, BCPS, BCCCP
Richard B. Lipton, MD
Hope O'Brien, MD, MBA, FAHS, FAAN
Cognitive Screening in MS: Practical Strategies and Modern Approaches
Elizabeth S. Gromisch, PhD
Advancing Cognitive Screening and Monitoring in MS
How Real-World Adherence Is Shaping Preventive Migraine Treatment
Alexandria May, PharmD, BCPS
Jessica Ailani, MD, FAHS, FAAN, FANA
Measuring Migraine: The Potential of CGRP
Shradha Kakde, MBBS
Improving Migraine Diagnosis in Vulnerable Populations
The Recovery Trajectory of Subarachnoid Hemorrhage
Subtle vs Syndromic: Distinguishing TD from Other DIMDs in the Neuro Clinic
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.